Update Regarding our Operations during COVID-19

20/04/2020

Dear Customers, Due to the SARS-CoV-2 outbreak, we have already notified you about changes in our operations. Please see below further amendments we would like to inform you about: Our Global Logistics Team continues all activities, but considering the service quality and transit unpredictability of all freight companies, Omixon decided to...

The New, Blazing Fast HLA Twin v4.2

31/03/2020

Two month ago, Omixon announced the release of the newest HLA Twin version which featured significant improvements in the software’s performance and responsiveness that facilitated the result review process and overall analysis workflow. Omixon team has been working on additional and even more significant improvements in HLA Twin. This time...

How Genetic Variation in the Immune System Predicts COVID-19 Disease Outcome

23/03/2020

Authors: Csaba Pal, Mate Manczinger, Attila Berces As we all know, the COVID-19 infectious disease caused by the SARS-CoV2 virus has spread globally. It is a significant and urgent medical threat with serious implications on our personal life and global economy. Therefore, it is of paramount importance to identify biomarkers...

Webinar – HLA Typing Uses in Research. How is HLA Explore Used to Facilitate it?

20/03/2020

Join us for a Webinar on Tuesday, April 7 with Efi Melista (Head of Product, Omixon) who will be talking about the uses of HLA typing in research and population studies, and how Omixon’s HLA Explore can facilitate it. Examples in disease associations, pharmacogenetics, drug sensitivities and overall population genetics...

Omixon Welcomes Gregory Werner as VP Commercial Operations

17/03/2020

Omixon is delighted to announce that Gregory Werner joined Omixon as Vice President Commercial Operations, effective March 16, 2020. About Greg Greg earned his Bachelor of Science in Biology and Biochemistry from University Savoie-Mont Blanc and also holds a M.Sc. in Molecular Biology and Genetic Engineering in addition to a Post...